Literature DB >> 18483250

Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels.

Tricia Moore1, Steve Carbajal, Linda Beltran, Susan N Perkins, Shoshana Yakar, Derek Leroith, Stephen D Hursting, John Digiovanni.   

Abstract

Calorie restriction has been shown to inhibit epithelial carcinogenesis and this method of dietary restriction reduces many circulating proteins, including insulin-like growth factor I (IGF-I). Previously, we identified a relationship between elevated tissue IGF-I levels and enhanced susceptibility to chemically induced skin tumorigenesis. In this study, liver IGF-I-deficient (LID) mice, which have a 75% reduction in serum IGF-I, were subjected to the standard two-stage skin carcinogenesis protocol using 7,12-dimethylbenz(a)anthracene as the initiator and 12-O-tetradecanoylphorbol-13-acetate (TPA) as the promoter. We observed a significant reduction in epidermal thickness and labeling index in LID mice treated with either vehicle or TPA. A significant decrease in both tumor incidence and tumor multiplicity was observed in LID mice undergoing two-stage skin carcinogenesis relative to wild-type littermates. Western blot analyses of epidermal extracts revealed reduced activation of both the epidermal growth factor and IGF-I receptors in response to TPA treatment in LID mice. In addition, reduced activation of both Akt and the mammalian target of rapamycin (mTOR) was observed in LID mice following TPA treatment relative to wild-type controls. Signaling downstream of mTOR was also reduced. These data suggest a possible mechanism whereby reduced circulating IGF-I leads to attenuated activation of the Akt and mTOR signaling pathways, and thus, diminished epidermal response to tumor promotion, and ultimately, two-stage skin carcinogenesis. The current data also suggest that reduced circulating IGF-I levels which occur as a result of calorie restriction may lead to the inhibition of skin tumorigenesis, at least in part, by a similar mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483250     DOI: 10.1158/0008-5472.CAN-07-6271

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

2.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

3.  Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk.

Authors:  Tricia Moore; Linda Beltran; Steve Carbajal; Stephen D Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2012-08-15

Review 4.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

5.  Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice.

Authors:  Susan E Olivo-Marston; Stephen D Hursting; Jackie Lavigne; Susan N Perkins; Rami S Maarouf; Shoshana Yakar; Curtis C Harris
Journal:  Mol Carcinog       Date:  2009-12       Impact factor: 4.784

6.  Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.

Authors:  Erika L Abel; Joe M Angel; Kaoru Kiguchi; John DiGiovanni
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

7.  Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.

Authors:  Brendan J Quinn; Matthew Dallos; Hiroshi Kitagawa; Ajaikumar B Kunnumakkara; Regan M Memmott; M Christine Hollander; Joell J Gills; Phillip A Dennis
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-14

8.  Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.

Authors:  Robert E Carroll; Robert A Goodlad; Aleksandra J Poole; Angela L Tyner; R Brooks Robey; Steven M Swanson; Terry G Unterman
Journal:  Growth Horm IGF Res       Date:  2009-04-29       Impact factor: 2.372

9.  Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.

Authors:  Po-Chen Chu; Samuel K Kulp; Ching-Shih Chen
Journal:  Carcinogenesis       Date:  2013-07-16       Impact factor: 4.944

10.  Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I.

Authors:  Laura M Lashinger; Lauren M Harrison; Audrey J Rasmussen; Craig D Logsdon; Susan M Fischer; Mark J McArthur; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.